We are proud to announce that SyVento BioTech, as a member of the Alliance for mRNA Medicines (AMM), will be participating in the upcoming 2nd Annual Meeting -AMM Ascent – taking place on 16–18 September 2025, at the Coronado Island, California.

This premier summit gathers senior executives and top decision-makers across the hasztag#mRNA landscape. Attendees gain exclusive access to partnering, networking, keynotes, fireside chats, and plenary discussions – all aimed at advancing breakthroughs in mRNA science, commercialization, education, and novel technologies.

Representing SyVento BioTech will be:
» Dominik Lipka PhD Eng., CTO
» Sujit Jain, our newly appointed Commercial Advisor

At SyVento, we are committed to accelerating the future of mRNA-based therapeutics through our expertise in RNA synthesis, advanced delivery systems, and scalable GMP manufacturing. Events like AMM ASCENT are the perfect platform to share knowledge, explore collaborations, and push the boundaries of what’s possible in next-generation medicine.

We look forward to connecting in Coronado Island next week!